Impact of Probiotics on Children with Acute Gastroenteritis: Results from an Umbrella Meta-Analysis

Sen Fan1, Xianchun Mao1, Ranran Li1

  • 1Department of Pediatrics, Shandong Provincial Third Hospital, Shandong University, Tianqiao District, Jinan City, Shandong Province, China.

Insights

Probiotics can help prevent acute gastroenteritis (AG) in children and reduce symptoms like diarrhea and vomiting. Specific strains, doses, and durations are key for optimal effectiveness in treating pediatric AG.

Area of Science:

  • Pediatric Gastroenterology
  • Microbiome Research
  • Clinical Pharmacology

Background:

  • Probiotics are explored for treating acute gastroenteritis (AG) in children.
  • Optimal probiotic strains, dosages, and treatment durations for AG remain undetermined.

Purpose of the Study:

  • To conduct an umbrella meta-analysis assessing the clinical efficacy of various probiotic strains on pediatric acute gastroenteritis.

Main Methods:

  • Systematic literature search of PubMed and Scopus up to October 12, 2025.
  • Included 36 meta-analyses with 107,541 participants.
  • Analyzed continuous and binary outcomes using standardized mean difference and relative risk.

Main Results:

  • Probiotics may prevent AG and reduce diarrhea duration, vomiting, fever, and hospital stays.
  • Effects are strain-specific and influenced by dose (CFUs) and duration.
  • Effective strains include *Saccharomyces boulardii CNCM I-745*, *Lacticaseibacillus rhamnosus GG*, and others.

Conclusions:

  • Probiotics demonstrate potential in preventing AG and alleviating its symptoms in pediatric populations.
  • Strain selection, dosage, and duration are critical factors for probiotic efficacy in AG treatment.
Abstract

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
296
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
88
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
602
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
222
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967